https://www.selleckchem.com/products/apx2009.html
Grade 3 and 4 adverse events were reported by 4% of patients during procedure and by 10% within 30days. While 38% reported a worse, 62% reported a stable or better global health score, and 54% of patients with worse global health scorewere treated as salvage therapy patients. This interim analysis confirms in a prospective analysis the feasibility of the study, with an acceptable toxicity profile. More patients reported a stable or improved HRQOL than deterioration. Deterioration of HRQOL was seen especially in salvage therapy patients.
Curtir
Comentario
Compartilhar
